Pharma Investments, Ventures & Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Investments, Ventures & Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Acute Lymphoblastic Leukemia
Scientists at University of California, Department of Hematology-Oncology publish research in acute lymphoblastic leukemia in children
March 2nd, 2008
Data detailed in 'Molecular allelokaryotyping of pediatric acute lymphoblastic leukemias by high-resolution single nucleotide polymorphism oligonucleotide genomic microarray' have been presented. "Pediatric acute lymphoblastic leukemia (ALL) is a malignant disease resulting from accumulation of genetic alterations. A robust technology, single nucleotide polymorphism oligonucleotide genomic microarray (SNP-chip) in concert with bioinformatics offers the opportunity to discover the genetic lesions associated with ALL," scientists in the United States report. "We examined 399 pediatric ALL samples and their matched remission marrows at 50,000/250,000 SNP sites using an...
Source: Pharma Investments, Ventures & Law Weekly (2008-03-02)
|
